ONCY:NASDAQ
Oncolytics Biotech Inc
$ 0.67
arrow_upward
+1.19%(+0.0079) 1D
9-р сарын 29, 11:04:02 (GMT-4) · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$ 0.67
High
$ 0.68
Low
$ 0.66
Mkt. cap
85.94 сая
Avg. vol.
955.48 мян
Volume
160.69 мян
52-wk high
$ 1.47
52-wk low
$ 0.64
Beta
1.15
Shares outstanding
127.51 сая
No. of employees
29
Open
$ 0.67
High
$ 0.68
Low
$ 0.66
Mkt. cap
85.94 сая
Avg. vol.
955.48 мян
Volume
160.69 мян
52-wk high
$ 1.47
52-wk low
$ 0.64
Beta
1.15
Shares outstanding
127.51 сая
No. of employees
29
News stories
From web sources and news partners
Investing.com Canada
·
47 минутын өмнө
Form 8K Oncolytics Biotech Inc. For: 29 September By Investing.com
TipRanks
·
52 минутын өмнө
Oncolytics Biotech Highlights Pelareorep’s Tumor-Activating Potential
Investing.com Canada
·
1 цагийн өмнө
Oncolytics reports pelareorep data in liver cancer study By Investing.com
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc